
Revaly is built to solve one of the most costly and overlooked problems in subscription commerce: legitimate payments failing for preventable reasons. Its end-to-end Payment Performance Management platform leverages machine learning, issuer intelligence, and ecosystem data to elevate approval rates starting from the very first transaction attempt. The system automatically detects issues such as mistyped card numbers, routing mismatches, and metadata errors before a customer ever checks out. When payments do fail, Revaly uses a sophisticated retry engine that studies customer behavior, card network patterns, and historical success windows to recover revenue without damaging relationships. Businesses across industries report dramatic improvements—from 34% to over 50% increases in recovered payments—demonstrating the compound value of consistent, optimized approvals. Revaly’s integration ecosystem makes adoption frictionless, connecting seamlessly with CRMs, billing systems, payment gateways, and processors already in use. The platform not only protects revenue but stabilizes growth by reducing churn that comes from unintentional payment failures. Leadership teams gain visibility into payment performance metrics that go far beyond authorization rates, revealing hidden revenue opportunities and operational inefficiencies. As a result, companies can build smarter billing strategies and deliver a more reliable experience for customers. Revaly becomes a trusted partner in improving profitability, ensuring that when a customer says “yes,” the payment system does too.
Learn more

Creator marketing delivers its biggest impact when it operates as a growth engine, not a series of one-off campaigns.
Superfiliate gives brands one place to manage every creator relationship—from influencers and affiliates to ambassadors and paid partnerships—without juggling multiple platforms. With built-in creator discovery, automated workflows, unified reporting, and personalized experiences, brands can scale programs efficiently while understanding exactly what's driving revenue.
Brands like Graza, Cymbiotika, Omnilux, and MUD\WTR use Superfiliate to turn creator activity into a predictable acquisition channel. High-performing creator content fuels paid media, successful partnerships are easy to expand, and every campaign contributes to long-term growth.
By connecting directly with Meta, TikTok Shop, and YouTube, Superfiliate brings creator, content, and revenue data together in one place. Instead of piecing together performance across disconnected tools, brands gain the visibility they need to invest in the creators and content that generate the greatest business impact.
Learn more
VeraChem
Established in 2000, VeraChem LLC is dedicated to advancing the realms of computer-aided drug discovery and molecular design by developing sophisticated computational chemistry methods that integrate groundbreaking scientific principles with real-world research applications. A fundamental component of the company’s approach to product innovation is providing high-performance software solutions paired with comprehensive user assistance. VeraChem’s software currently boasts capabilities such as predicting protein-ligand and host-guest binding affinities, executing rapid and accurate computations of partial atomic charges for drug-like substances, and calculating energies and forces using popular empirical force fields. Furthermore, the software includes features for the automatic generation of alternative resonance forms for drug-like molecules, an efficient conformational search powered by the Tork algorithm, and the automated detection of topological and three-dimensional molecular symmetries. The modular design of VeraChem’s software packages facilitates adaptability and flexibility, allowing users to tailor these tools to meet a variety of research demands effectively. By providing such versatile resources, VeraChem empowers researchers to enhance their investigative efforts in drug discovery.
Learn more
SILCS
Site-Identification by Ligand Competitive Saturation (SILCS) generates three-dimensional representations called FragMaps, which depict the interactions of various chemical functional groups with a designated target molecule. By uncovering the intricacies of molecular dynamics, SILCS provides essential tools that facilitate the refinement of ligand scaffolds, offering both qualitative and quantitative perspectives on binding sites, which ultimately aids in optimizing the drug design workflow. This methodology utilizes a selection of small molecule probes, each possessing a variety of functional groups, along with explicit solvent modeling and the flexibility of the target molecule to effectively map protein targets. Moreover, the technique empowers researchers to visualize beneficial interactions with the target macromolecule, allowing for a more informed design process. Armed with these insights, scientists can strategically engineer enhanced ligands with functional groups positioned for maximum efficacy. The pioneering approach of SILCS marks a noteworthy leap forward in the realm of medicinal chemistry, opening new avenues for drug discovery and development. Through its advanced analytical capabilities, SILCS not only enhances understanding but also drives innovation in therapeutic design.
Learn more